Recent Finacing
Recent Raise
CanSense develops a blood-based early-stage bowel cancer diagnostic that combines laser spectroscopy and AI for faster, less invasive detection and is undergoing clinical development toward regulatory approval.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at CanSense.
